News

Huntington’s disease causes involuntary movements and dementia, has no cure, and is fatal. For the first time, UC Riverside scientists have shown they can slow its progression in flies and worms, opening the door to human treatments.

NIH study suggests the brain’s “salience network” is important for understanding substance use disorder, could be a future therapeutic target.

Neuroimaging in an adept meditator revealed rich patterns of brain activity in specific cortical, subcortical, brainstem, and cerebellar regions associated with an advanced practice of meditation called jhana.

A drug that prevents the accumulation of damaged mitochondria has shown promise for treating ALS in a mouse study.

Manganese is both an essential nutrient and a toxic chemical, exposure to which may be beneficial for verbal learning and memory in early adolescence.

An analysis of Maryland ketamine advertisers has suggested that their websites and marketing materials are awash with false and misleading claims about the drug’s addictiveness, side effects and approval status.

Researchers shows why only a subset of individuals exposed to trauma develop posttraumatic stress disorder (PTSD). The research, centered on the body's stress hormone response, could pave the way for more targeted treatments for PTSD.

Researchers from Edge Hill University have found that there is a gender bias towards males when associating autistic traits, which may impact the identification of autism in females.

New calculations show European countries have great potential for reducing demand for global food resources and associated GHG footprint. Researchers have estimated the climate footprint savings that may be obtained from reducing food loss and waste.

New research has illustrated that altered treatments after treatment options are considered exhausted can still benefit Parkinson's patients.